Page last updated: 2024-12-07

xanthurenic acid 8-methyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxy-8-methoxyquinaldic acid : A quinolinemonocarboxylic acid that is kynurenic acid which is substituted by a methoxy group at position 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID76230
CHEBI ID2323
SCHEMBL ID975858
MeSH IDM0081139

Synonyms (30)

Synonym
brn 0202789
xanthurenic acid-8-methyl ether
quinaldic acid, 4-hydroxy-8-methoxy-
4-hydroxy-8-methoxyquinaldic acid
8-methoxy-4-hydroxyquinoline-2-carboxylic acid
8-methyl ether of xanthurenic acid
4-hydroxy-8-methoxy-2-quinolinecarboxylic acid
8-methoxyxanthurenic acid
92u92j5x9a ,
unii-92u92j5x9a
2929-14-8
C05830
8-methoxykynurenate
xanthurenic acid 8-methyl ether
OPREA1_564088
AKOS000189455
8-methoxy-4-oxo-1h-quinoline-2-carboxylic acid
CCG-127197
4-hydroxy-8-methoxyquinoline-2-carboxylic acid
CHEBI:2323
8-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid
8-methoxykynurenic acid
SCHEMBL975858
DTXSID20183541
2-quinolinecarboxylic acid, 4-hydroxy-8-methoxy-
93445-77-3
8-methoxy-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid
Q27105632
SB70690
EN300-6745611
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
quinolinemonocarboxylic acidAny aromatic carboxylic acid that contains a quinoline moiety that is substituted by one carboxy substituent.
monohydroxyquinolineA hydroxyquinoline carrying a single hydroxy substituent.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]